Shimeng Liu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Health Promotion

Newly Diagnosed

Top Venues

JMIR public health and surveillance

Global health research and policy

Patient preference and adherence

Journal of neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Limin Wang, Shimeng Liu, Shan Jiang, Chaofan Li, Liyong Lu, Yunhai Fang, ShunPing Li
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies". JMIR public health and surveillance 10 (2024)
Shimeng Liu, Yu Xia, Yi Yang, Jian Ming, Hui Sun, Yan Wei, Yingyao Chen
Mapping of health technology assessment in China: a comparative study between 2016 and 2021. Global health research and policy 9 (1) (2024)
Shimeng Liu, Yu Xia, Yi Yang, Jian Ming, Hui Sun, Yan Wei, Yingyao Chen
Mapping of health technology assessment in China: a comparative study between 2016 and 2021. Global health research and policy 9 (1) (2024)
Yuliang Xiang, Yingyao Chen, Zian Xu, Shanyan Zhou, Zhiyong Qin, Lingchao Chen, Dunming Xiao, Shimeng Liu
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China. Journal of neuro-oncology (2024)
Yuliang Xiang, Yingyao Chen, Zian Xu, Shanyan Zhou, Zhiyong Qin, Lingchao Chen, Dunming Xiao, Shimeng Liu
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China. Journal of neuro-oncology 168 (2) (2024)
Limin Wang, Shimeng Liu, Shan Jiang, Chaofan Li, Liyong Lu, Yunhai Fang, ShunPing Li
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies". JMIR public health and surveillance 10 (2024)
Fuming Li, Shimeng Liu, Yuanyuan Gu, ShunPing Li, Ying Tao, Yan Wei, Yingyao Chen
Comparing the Self-Reported Acceptability of Discrete Choice Experiment and Best-Worst Scaling: An Empirical Study in Patients with Type 2 Diabetes Mellitus. Patient preference and adherence 18 (2024)
Limin Wang, Shimeng Liu, Shan Jiang, Chaofan Li, Liyong Lu, Yunhai Fang, ShunPing Li
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies". JMIR public health and surveillance 10 (2024)
Shimeng Liu, Yu Xia, Yi Yang, Jian Ming, Hui Sun, Yan Wei, Yingyao Chen
Mapping of health technology assessment in China: a comparative study between 2016 and 2021. Global health research and policy 9 (1) (2024)
Fuming Li, Shimeng Liu, Yuanyuan Gu, ShunPing Li, Ying Tao, Yan Wei, Yingyao Chen
Comparing the Self-Reported Acceptability of Discrete Choice Experiment and Best-Worst Scaling: An Empirical Study in Patients with Type 2 Diabetes Mellitus. Patient preference and adherence 18 (2024)
Limin Wang, Shimeng Liu, Shan Jiang, Chaofan Li, Liyong Lu, Yunhai Fang, ShunPing Li
Authors' Reply: "The Need for a Bleed Type-Specific Annual Bleeding Rate in Hemophilia Studies". JMIR public health and surveillance 10 (2024)
Limin Wang, Shimeng Liu, Shan Jiang, Chaofan Li, Liyong Lu, Yunhai Fang, ShunPing Li
Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study. JMIR public health and surveillance 9 (2023)
Shimeng Liu, Jing Liu, Lei Si, Xiong Ke, Liu Liu, Yanfeng Ren, Shiyi Bao, Fuming Li, Yijiang Yu, Qi Pan, Yan Wei, Yingyao Chen
Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey. BMJ global health 8 (4) (2023)